<!DOCTYPE html>
<html lang="en-gb">
<head>
  
  <meta charset="utf-8" />
  <meta content="IE=edge,chrome=1" name="X-UA-Compatible" />
  <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport" />
  
  <!-- meta tags -->
  <meta content="NICE" name="DC.Publisher" />
  <meta content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." name="DC.Rights.Copyright" />
  <meta content="eng" name="DC.Language" scheme="DCTERMS.ISO639-2T" />
  <meta content="Health, well-being and care" name="DC.Subject" scheme="eGMS.IPSV" />
  <meta content="Double-A" name="eGMS.accessibility" scheme="eGMS.WCAG10" />
  <meta content="2014-08-05" name="DC.Issued" scheme="DCTERMS.W3CDTF" />
  <meta content="2014-08-05" name="DC.Modified" scheme="DCTERMS.W3CDTF" />
  <meta content="CorporatePage" name="DC.Type" scheme="NICE.Publication.Types" />
  
  <meta content="BNF: British National Formulary - NICE" name="DC.Title" />
  
  <title>ATROPINE SULFATE | Drug | BNF content published by NICE</title>
  <meta name="description" content="Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for ATROPINE SULFATE."/>
  <meta name="author" content="NICE - The National Institute for Health and Care Excellence" />

  	<link rel="alternate" type="application/json" href="/drug/atropine-sulfate.json" title="RDF/JSON version of this document"/>
  	<link rel="alternate" type="text/turtle" href="/drug/atropine-sulfate.ttl" title="Turtle version of this document"/>
  <!--[if lt IE 9]>
  <script src="//cdn.nice.org.uk/V3.1/Scripts/html5shiv/html5shiv.js"></script>
  <![endif]-->
  
  <!-- Le styles -->
  <link href="//fonts.googleapis.com/css?family=Lato:300normal,300italic,400normal,400italic,700normal,700italic" rel="stylesheet"/>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.bootstrap.css" rel="stylesheet">
  <link rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css">
  
  <!--[if IE 7]>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.glyphs-ie7.css" rel="stylesheet"/>
  <![endif]-->
  
  <meta content="#f6f6f6" name="msapplication-TileColor" />
  <meta content="//cdn.nice.org.uk/V3.1/Content/nice/favicon-144.png" name="msapplication-TileImage" />
  <link rel="shortcut icon" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon.ico" />
  <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon-152.png">
  
  <link href="/styles/style.css" rel="stylesheet" type="text/css" />
  <link href="/styles/bnf.css" rel="stylesheet" type="text/css" />
</head>
<body id="atropine-sulfate" class="drug" data-publication="bnf" data-buildnumber="1.0.119-Live" data-release="live">
  
  
  <!-- Google Tag Manager -->
  <div id='gtmscript'></div>
  <noscript>
    <iframe src="//www.googletagmanager.com/ns.html?id=GTM-WF3WHX"
      height="0" width="0" style="display:none;visibility:hidden"></iframe>
  </noscript>
  <script>
    (function (w, d, s, l, i) {
      w[l] = w[l] || []; w[l].push({
        'gtm.start': new Date().getTime(), event: 'gtm.js'
      }); var f = d.getElementsByTagName(s)[0],
              j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
    })(window, document, 'script', 'dataLayer', 'GTM-WF3WHX');
  </script>
  <!-- End Google Tag Manager -->
  <div id="global-nav-header"></div>  <div class="container topic-container">
    
    <ul class="breadcrumb">
      <li><a href="../">Home</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li><a href="./">Drugs</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li class="active"><span>ATROPINE SULFATE</span></li>
    </ul>
  </div>
  
	<div class="container sticky-notice">
			<div id="site-distinction" class="bnf">
				<p>You are viewing BNF. If you require BNF for Children, use <a href="https://bnfc.nice.org.uk">BNFC.</a></p>
			</div>	</div>

  <div class="layout search-container hidden">
    <div id="search-results">
    </div>
  </div>
  <div class="layout">
    <h1 id=""><span>ATROPINE SULFATE</span></h1>
  </div>


  <div class="layout layout-secondary-wide topic-container">

    <div class="content content-primary">
      <nav class="nav-toggle">
        <ul class="index unstyled nav-subtopics">
          <li>
            <a class="btn btn-transparent">
              <i class="pull-right icon-chevron-down"></i>
              <span>Show all parts of this monograph</span>
            </a>
          </li>
        </ul>
      </nav>

      <nav class="monograph-navigation">
        <ul class="index unstyled nav-subtopics grid2">
            <li class="active"><a href="#indicationsAndDoses" class="scroll-to-href">Indications and dose</a></li>
            <li><a href="#unlicensedUse" class="scroll-to-href">Unlicensed use</a></li>
            <li><a href="#importantSafetyInformations" class="scroll-to-href">Important safety information</a></li>
            <li><a href="#contraIndications" class="scroll-to-href">Contra-indications</a></li>
            <li><a href="#cautions" class="scroll-to-href">Cautions</a></li>
          <li><a href="#interactions" class="scroll-to-href">Interactions</a></li>
            <li><a href="#sideEffects" class="scroll-to-href">Side-effects</a></li>
            <li><a href="#pregnancy" class="scroll-to-href">Pregnancy</a></li>
            <li><a href="#breastfeeding" class="scroll-to-href">Breast feeding</a></li>
            <li><a href="#monitoringRequirements" class="scroll-to-href">Monitoring requirements</a></li>
            <li><a href="#directionsForAdministration" class="scroll-to-href">Directions for administration</a></li>
            <li><a href="#prescribingAndDispensingInformations" class="scroll-to-href">Prescribing and dispensing information</a></li>
            <li><a href="#patientAndCarerAdvice" class="scroll-to-href">Patient and carer advice</a></li>
            <li><a href="#lessSuitableForPrescribings" class="scroll-to-href">Less suitable for prescribing</a></li>
            <li><a href="#exceptionsToLegalCategory" class="scroll-to-href">Exceptions to legal category</a></li>
            <li><a href="#medicinalForms" class="scroll-to-href">Medicinal forms</a></li>
        </ul>
      </nav>

      <div id="monograph-content" class="">
      
        <section class="scroll-target" id="indicationsAndDoses">
          <h2>Indications and dose</h2>
      
      
          <div class="prescribingInformation">
          <section class="indicationsAndDose">
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Cycloplegia</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">To the eye using eye drop</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>(consult product literature).</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Anterior uveitis</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">To the eye using eye drop</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>(consult product literature).</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Bradycardia due to acute massive overdosage of beta-blockers</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child</span>
                    </span></strong><br/>
                    <p>40&#8239;micrograms/kg (max. per dose 3&#8239;mg).</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>3&#8239;mg.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Treatment of poisoning by organophosphorus insecticide or nerve agent (in combination with pralidoxime chloride)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child</span>
                    </span></strong><br/>
                    <p>20&#8239;micrograms/kg every 5&#8211;10&#8239;minutes (max. per dose 2&#8239;mg) until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>2&#8239;mg every 5&#8211;10&#8239;minutes until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Symptomatic relief of gastro-intestinal disorders characterised by smooth muscle spasm</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>0.6&#8211;1.2&#8239;mg daily, dose to be taken at night.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Premedication</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>300&#8211;600&#8239;micrograms, to be administered immediately before induction of anaesthesia.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>300&#8211;600&#8239;micrograms, to be administered immediately before induction of anaesthesia.</p>
                  </li>
                </ul>
              </div>
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By subcutaneous injection, or by intramuscular injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>300&#8211;600&#8239;micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>300&#8211;600&#8239;micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Intra-operative bradycardia</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>300&#8211;600&#8239;micrograms, larger doses may be used in emergencies.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>300&#8211;600&#8239;micrograms, larger doses may be used in emergencies.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>0.6&#8211;1.2&#8239;mg.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>0.6&#8211;1.2&#8239;mg.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Excessive bradycardia associated with beta-blocker use</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>0.6&#8211;2.4&#8239;mg in divided doses (max. per dose 600&#8239;micrograms).</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Bradycardia following myocardial infarction (particularly if complicated by hypotension)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>500&#8239;micrograms every 3&#8211;5&#8239;minutes; maximum 3&#8239;mg per course.</p>
                  </li>
                </ul>
              </div>
            </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="unlicensedUse">
          <h2>Unlicensed use</h2>
      
      
          <div class="prescribingInformation">
          <section class="unlicencedUse">
              <section class="advice UnlicencedUse">
                <p class="specificity"><strong><span class="specificity">When used by <span class="route">eye</span> in children</span></strong></p>
                <div>
                              
                              <p>Not licensed for use in children for uveitis.</p>
                            </div>
              </section>
              <section class="advice UnlicencedUse">
                <p class="specificity"><strong><span class="specificity">With <span class="route">systemic</span> use in children</span></strong></p>
                <div>
                              
                              <p>Not licensed for use in children under 12 years for intra-operative bradycardia or by intravenous route for premedication.</p>
                            </div>
              </section>
              <section class="advice UnlicencedUse">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in children</span></strong></p>
                <div>
                              
                              <p>Not licensed for use by oral route.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="importantSafetyInformations">
          <h2>Important safety information</h2>
      
      
          <div class="prescribingInformation">
          <section class="importantSafetyInformation">
              <section class="advice ImportantSafetyInformation">
                <p class="specificity"><strong><span class="specificity">With <span class="route">systemic</span> use for <span class="indication">Premedication</span></span></strong></p>
                <div>
                              
                              <p>Antimuscarinic drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="contraIndications">
          <h2>Contra-indications</h2>
      
            <h3>For all <span>ANTIMUSCARINICS (SYSTEMIC)</span></h3>
            <div id="antimuscarinics-systemic_contraIndications">
              <p><a href="/drug-class/antimuscarinics-systemic.html#contraIndications" data-action="load" data-target="#antimuscarinics-systemic_contraIndications" data-filter="#contraIndications .prescribingInformation">See <span>ANTIMUSCARINICS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="cautions">
          <h2>Cautions</h2>
      
            <h3>For all <span>ANTIMUSCARINICS (EYE)</span></h3>
            <div id="antimuscarinics-eye_cautions">
              <p><a href="/drug-class/antimuscarinics-eye.html#cautions" data-action="load" data-target="#antimuscarinics-eye_cautions" data-filter="#cautions .prescribingInformation">See <span>ANTIMUSCARINICS (EYE)</span></a></p>
            </div>
            <h3>For all <span>ANTIMUSCARINICS (SYSTEMIC)</span></h3>
            <div id="antimuscarinics-systemic_cautions">
              <p><a href="/drug-class/antimuscarinics-systemic.html#cautions" data-action="load" data-target="#antimuscarinics-systemic_cautions" data-filter="#cautions .prescribingInformation">See <span>ANTIMUSCARINICS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="interactions">
          <h2>Interactions</h2>
      
      
          <div class="prescribingInformation">
          <section class="interactionStatement">
              <section class="advice InteractionStatement">
                <h4>Route-specific information</h4>
                <div>
                              
                              <p>Since systemic absorption can follow topical application, the possibility of interactions should be borne in mind.</p>
                            </div>
              </section>
          </section>
          </div>
      
          <div class="interactants">
            <h4>Individual interactants:</h4>
            <ul>
              <li><a href="/interaction/atropine.html" class="interactant"><span> Atropine </span></a></li>
            </ul>
          </div>
      
        </section>
      
        <section class="scroll-target" id="sideEffects">
          <h2>Side-effects</h2>
      
            <h3>For all <span>ANTIMUSCARINICS (EYE)</span></h3>
            <div id="antimuscarinics-eye_sideEffects">
              <p><a href="/drug-class/antimuscarinics-eye.html#sideEffects" data-action="load" data-target="#antimuscarinics-eye_sideEffects" data-filter="#sideEffects .prescribingInformation">See <span>ANTIMUSCARINICS (EYE)</span></a></p>
            </div>
            <h3>For all <span>ANTIMUSCARINICS (SYSTEMIC)</span></h3>
            <div id="antimuscarinics-systemic_sideEffects">
              <p><a href="/drug-class/antimuscarinics-systemic.html#sideEffects" data-action="load" data-target="#antimuscarinics-systemic_sideEffects" data-filter="#sideEffects .prescribingInformation">See <span>ANTIMUSCARINICS (SYSTEMIC)</span></a></p>
            </div>
      
          <h3>For <span>ATROPINE SULFATE</span></h3>
          <div class="prescribingInformation">
          <section class="specificSideEffects">
            <section class="SideEffectsWithRoutes">
              <div class="commonOrVeryCommon">
                <h4>Common or very common</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                    <p>
                    <span class="sideEffect">abdominal distension</span>; <span class="sideEffect">anhidrosis</span>; <span class="sideEffect">anxiety</span>; <span class="sideEffect">arrhythmias</span>; <span class="sideEffect">bronchial secretion decreased</span>; <span class="sideEffect">dysphagia</span>; <span class="sideEffect">gastrointestinal disorders</span>; <span class="sideEffect">hallucination</span>; <span class="sideEffect">hyperthermia</span>; <span class="sideEffect">movement disorders</span>; <span class="sideEffect">mydriasis</span>; <span class="sideEffect">speech disorder</span>; <span class="sideEffect">taste loss</span>; <span class="sideEffect">thirst</span></p>
                  </section>
              </div>
              <div class="uncommon">
                <h4>Uncommon</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                    <p>
                                        <span class="sideEffect">psychotic disorder</span>
                                      </p>
                  </section>
              </div>
              <div class="rareOrVeryRare">
                <h4>Rare or very rare</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                    <p>
                    <span class="sideEffect">angina pectoris</span>; <span class="sideEffect">hypertensive crisis</span>; <span class="sideEffect">seizure</span></p>
                  </section>
              </div>
              <div class="notKnown">
                <h4>Frequency not known</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                    <p>
                                        <span class="sideEffect">insomnia</span>
                                      </p>
                  </section>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                    <p>
                    <span class="sideEffect">angle closure glaucoma</span>; <span class="sideEffect">arrhythmias</span>; <span class="sideEffect">bronchial secretion altered</span>; <span class="sideEffect">chest pain</span>; <span class="sideEffect">dysphagia</span>; <span class="sideEffect">fever</span>; <span class="sideEffect">gastrointestinal disorders</span>; <span class="sideEffect">mydriasis</span>; <span class="sideEffect">staggering</span>; <span class="sideEffect">thirst</span></p>
                  </section>
              </div>
            </section>
          </section>
          <div class="sideEffectAdvice">
            <h3>Side-effects, further information</h3>
              <section class="advice SideEffectAdvice">
                <div>
                              <p>
                                <strong>When used by eye (topical)</strong>
                              </p>
                              <p>Systemic side-effects can occur.</p>
                            </div>
              </section>
          </div>
          </div>
      
        </section>
      
      
      
        <section class="scroll-target" id="pregnancy">
          <h2>Pregnancy</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalInformation">
              <section class="advice GeneralInformation">
                <p class="specificity"><strong><span class="specificity">With <span class="route">systemic</span> use</span></strong></p>
                <div>
                              
                              <p>Not known to be harmful; manufacturer advises caution.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="breastfeeding">
          <h2>Breast feeding</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalInformation">
            
              <section class="advice GeneralInformation">
                <p class="specificity"><strong><span class="specificity">With <span class="route">systemic</span> use</span></strong></p>
                <div>
                              
                              <p>May suppress lactation; small amount present in milk&#8212;manufacturer advises caution.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
      
      
        <section class="scroll-target" id="monitoringRequirements">
          <h2>Monitoring requirements</h2>
      
      
          <div class="prescribingInformation">
          <section class="monitoringOfPatientParameters">
            <h3>Monitoring of patient parameters</h3>
              <section class="advice MonitoringOfPatientParameters,MonitoringRequirement">
                <h4>Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block</h4>
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                <div>
                              
                              
                              <p>Since atropine has a shorter duration of action than neostigmine, late unopposed bradycardia may result; close monitoring of the patient is necessary.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
      
        <section class="scroll-target" id="directionsForAdministration">
          <h2>Directions for administration</h2>
      
      
          <div class="prescribingInformation">
          <section class="directionForAdministration">
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in children</span></strong></p>
                <div>
                              
                              <p>For administration <em>by mouth</em>, injection solution may be given orally.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="prescribingAndDispensingInformations">
          <h2>Prescribing and dispensing information</h2>
      
      
          <div class="prescribingInformation">
          <section class="prescribingAndDispensingInformation">
              <section class="advice PrescribingAndDispensingInformation">
                <p class="specificity"><strong><span class="specificity">When used by <span class="route">eye</span></span></strong></p>
                <div>
                              
                              <p>Although multi-dose atropine sulphate eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="patientAndCarerAdvice">
          <h2>Patient and carer advice</h2>
      
            <h3>For all <span>ANTIMUSCARINICS (EYE)</span></h3>
            <div id="antimuscarinics-eye_patientAndCarerAdvice">
              <p><a href="/drug-class/antimuscarinics-eye.html#patientAndCarerAdvice" data-action="load" data-target="#antimuscarinics-eye_patientAndCarerAdvice" data-filter="#patientAndCarerAdvice .prescribingInformation">See <span>ANTIMUSCARINICS (EYE)</span></a></p>
            </div>
            <h3>For all <span>ANTIMUSCARINICS (SYSTEMIC)</span></h3>
            <div id="antimuscarinics-systemic_patientAndCarerAdvice">
              <p><a href="/drug-class/antimuscarinics-systemic.html#patientAndCarerAdvice" data-action="load" data-target="#antimuscarinics-systemic_patientAndCarerAdvice" data-filter="#patientAndCarerAdvice .prescribingInformation">See <span>ANTIMUSCARINICS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
        </section>
      
      
      
        <section class="scroll-target" id="lessSuitableForPrescribings">
          <h2>Less suitable for prescribing</h2>
      
      
          <div class="prescribingInformation">
          <section class="lessSuitableForPrescribing">
              <section class="advice LessSuitableForPrescribing">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in adults</span></strong></p>
                <div>
                              
                              <p>Atropine tablets less suitable for prescribing. Any clinical benefit as a gastro-intestinal antispasmodic is outweighed by atropinic side-effects.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="exceptionsToLegalCategory">
          <h2>Exceptions to legal category</h2>
      
      
          <div class="prescribingInformation">
          <section class="exceptionToLegalCategory">
              <section class="advice ExceptionToLegalCategory">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intramuscular</span> use or <span class="route">intravenous</span> use or <span class="route">subcutaneous</span> use</span></strong></p>
                <div>
                              
                              <p>Prescription only medicine restriction does not apply where administration is for saving life in emergency.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="medicinalForms">
          <h2>Medicinal forms</h2>
      
          <section class="licensingVariationStatement">
            <p>There can be variation in the licensing of different medicines containing the same drug.</p>
          </section>
      
            <section class="availableFormsStatement">
              <p>Forms available from special-order manufacturers include: oral suspension, oral solution, solution for injection, solution for infusion, eye drops, eye ointment</p>
            </section>
      
          <section class="medicinalForms">
            <p><a href="../medicinal-forms/atropine-sulfate.html"><span>Tablet</span>,  <span>Solution for injection</span>,  <span>Eye drops</span> </a></p>
          </section>
        </section>
      </div>

      
      <div class="back-to-top-container">
        <a class="btn btn-default back-to-top">
        	<span class="hidden-xs">Back to top</span>
        	<span class="icon-chevron-up" style="padding: 0px 4px;"></span>
      	</a>
      </div>    </div>

    <div class="content content-secondary">

        <section class="related-links scroll-target related-treatment-summary" id="related-treatment-summary">
          <h4>Related Treatment Summaries</h4>
          <ul class="">
            <li>
              <a href="../treatment-summary/antispasmodics.html" class="related-link"><span>Antispasmodics</span></a>
            </li>
            <li>
              <a href="../treatment-summary/arrhythmias.html" class="related-link"><span>Arrhythmias</span></a>
            </li>
            <li>
              <a href="../treatment-summary/cardiac-glycosides.html" class="related-link"><span>Cardiac glycosides</span></a>
            </li>
            <li>
              <a href="../treatment-summary/cardiopulmonary-resuscitation.html" class="related-link"><span>Cardiopulmonary resuscitation</span></a>
            </li>
            <li>
              <a href="../treatment-summary/mydriatics-and-cycloplegics.html" class="related-link"><span>Mydriatics and cycloplegics</span></a>
            </li>
            <li>
              <a href="../treatment-summary/neuromuscular-blockade-reversal.html" class="related-link"><span>Neuromuscular blockade reversal</span></a>
            </li>
            <li>
              <a href="../treatment-summary/neuromuscular-disorders.html" class="related-link"><span>Neuromuscular disorders</span></a>
            </li>
            <li>
              <a href="../treatment-summary/poisoning-emergency-treatment.html" class="related-link"><span>Poisoning, emergency treatment</span></a>
            </li>
            <li>
              <a href="../treatment-summary/pre-medication-and-peri-operative-drugs.html" class="related-link"><span>Pre-medication and peri-operative drugs</span></a>
            </li>
            <li>
              <a href="../treatment-summary/sympathomimetics.html" class="related-link"><span>Sympathomimetics</span></a>
            </li>
          </ul>
        </section>

        <section class="classifications scroll-target primary-classifications" id="primary-classifications">
          <div id="primary">
            <p>Other drugs classified as <a href="/drug-classification/primary/atropine-sulfate.html" data-target="#primary" data-action="load" class="classification primary-classification">antimuscarinics, other</a></p>
          </div>
        </section>

      

    </div>
  </div>

  
  <div id="global-nav-footer"></div>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/jquery/jquery-1.10.2.min.js"></script>
  
  
   
  <!-- Bootstrap  -->
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/twitter.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/NICE.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/nice/NICE.EventTracking.js"></script>
  
  <script src="/scripts/remoteload.js"></script>
  <script src="/scripts/NICE.scrollspy.js"></script>
  <script src="/scripts/NICE.asyoutype.js"></script>
  <script src="/scripts/stickyfill.min.js"></script>
  <script src="/scripts/NICE.bnf.js"></script>
    <script>
  	    (function( $ ) {
  	      $(function() {
  	        var $backToTop = $( '#backToTop' );
  	        var $win = $( window );
  	        var opt = { min: 500, fadeSpeed: 100, scrollSpeed: 300 };
  	  
  	        $( document.body ).on('click', '#backToTop', function( ev ) {
  	          ev.preventDefault();
  	  
  	          $( "html, body" ).animate({ scrollTop: 0 }, opt.scrollSpeed );
  	        });
  	  
  	        $win.on('scroll', function() {
  	          $backToTop[ 'fade' + ( $win.scrollTop() >= opt.min ? 'In' : 'Out' ) ]( opt.fadeSpeed );
  	        });
  	      });
  	    })( jQuery );
  	  </script>
  	  	<script> 
  				var queryMatch = window.location.hash.match("q=([^&]+)");
  				var searchPlaceHolder = "Search BNFâ¦";
  				var global_nav_config = {
  				service: "bnf",
  				header: {
  					skipLinkId: "content-start",
  					cookie: true,
  					auth: {
  						environment: "live" == "live" ? "live" : "beta",
  						provider: "niceAccounts"
  					},
  					search: {
  						url: "/search?q=",
  						query: queryMatch ? decodeURIComponent(queryMatch[1]) : "",
  						autocomplete: "/typeahead?ajax=ajax",
  						placeholder: searchPlaceHolder,
  						onSearching: function(e) {
  								window.location.href = "#Search?q=" + encodeURIComponent(e.query);
  						}
  					},
  					onRendered: "globalNavRendered"
  				}
  	  	};
  	  </script>
  	  
  			<!--[if lt IE 9]>
  					<script src="//cdn.nice.org.uk/global-nav/global-nav.ie8.min.js"></script>
  			<![endif]-->
  			<script src="//cdn.nice.org.uk/global-nav/global-nav.min.js"></script>
  	
  	  
  
  
  
  <!-- Test for touch device -->
  <script type="text/javascript">
    $('body').addClass('ontouchstart' in document.documentElement ? 'touch-screen-device' : 'non-touch-screen-device');
  </script>
  
  <!-- TODO: What is this doing? -->
  <script type="text/javascript">
    $(document).ajaxSend(function (event, jqxhr, settings) { settings.url = settings.url + (~settings.url.indexOf("?") ? "&" : "?")+ "ajax=ajax"; });
  </script></body>
</html>
